Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period.
Hiba DagherAnne-Marie ChaftariIshwaria M SubbiahAlexandre E MalekYing JiangPeter LamieBruno GranwehrTeny JohnEduardo YepezJovan BorjanCielito C Reyes-GibbyMary FloresFareed KhawajaMala PandeNoman AliRaniv RojoDaniel D KarpPatrick ChaftariRay HachemIssam I RaadPublished in: eLife (2023)
This research is supported by the National Institutes of Health/National Cancer Institute under award number P30CA016672, which supports the MD Anderson Cancer Center Clinical Trials Office. The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.
Keyphrases
- clinical trial
- end stage renal disease
- coronavirus disease
- ejection fraction
- newly diagnosed
- sars cov
- healthcare
- chronic kidney disease
- public health
- mental health
- papillary thyroid
- molecular dynamics
- quality improvement
- big data
- patient reported outcomes
- social media
- depressive symptoms
- climate change
- open label
- phase ii
- study protocol
- respiratory syndrome coronavirus
- protein kinase
- placebo controlled